Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.

Abstract:

:Current antidepressants act principally by blocking monoamine reuptake by high-affinity transporters in the brain. However, these antidepressants show important shortcomings such as slow action onset and limited efficacy in nearly a third of patients with major depression disorder. Here, we report the development of a prodrug targeting organic cation transporters (OCT), atypical monoamine transporters recently implicated in the regulation of mood. Using molecular modeling, we designed a selective OCT2 blocker, which was modified to increase brain penetration. This compound, H2-cyanome, was tested in a rodent model of chronic depression induced by 7-week corticosterone exposure. In male mice, prolonged administration of H2-cyanome induced positive effects on several behaviors mimicking symptoms of depression, including anhedonia, anxiety, social withdrawal, and memory impairment. Importantly, in this validated model, H2-cyanome compared favorably with the classical antidepressant fluoxetine, with a faster action on anhedonia and better anxiolytic effects. Integrated Z-scoring across these depression-like variables revealed a lower depression score for mice treated with H2-cyanome than for mice treated with fluoxetine for 3 weeks. Repeated H2-cyanome administration increased ventral tegmental area dopaminergic neuron firing, which may underlie its rapid action on anhedonia. H2-cyanome, like fluoxetine, also modulated several intracellular signaling pathways previously involved in antidepressant response. Our findings provide proof-of-concept of antidepressant efficacy of an OCT blocker, and a mechanistic framework for the development of new classes of antidepressants and therapeutic alternatives for resistant depression and other psychiatric disturbances such as anxiety.

journal_name

Mol Psychiatry

journal_title

Molecular psychiatry

authors

Orrico-Sanchez A,Chausset-Boissarie L,Alves de Sousa R,Coutens B,Rezai Amin S,Vialou V,Louis F,Hessani A,Dansette PM,Zornoza T,Gruszczynski C,Giros B,Guiard BP,Acher F,Pietrancosta N,Gautron S

doi

10.1038/s41380-019-0548-4

subject

Has Abstract

pub_date

2020-06-01 00:00:00

pages

1245-1259

issue

6

eissn

1359-4184

issn

1476-5578

pii

10.1038/s41380-019-0548-4

journal_volume

25

pub_type

杂志文章
  • Right parietal dysfunction in children with attention deficit hyperactivity disorder, combined type: a functional MRI study.

    abstract::Attention deficit hyperactivity disorder, combined type (ADHD-CT) is associated with spatial working memory deficits. These deficits are known to be subserved by dysfunction of neural circuits involving right prefrontal, striatal and parietal brain regions. This study determines whether decreased right prefrontal, str...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4001999

    authors: Vance A,Silk TJ,Casey M,Rinehart NJ,Bradshaw JL,Bellgrove MA,Cunnington R

    更新日期:2007-09-01 00:00:00

  • Cure therapeutics and strategic prevention: raising the bar for mental health research.

    abstract::Mental disorders cause more disability than any other class of medical illness in Americans between ages 15 and 44 years. The suicide rate is higher than the annual mortality from homicide, AIDS, and most forms of cancer. In contrast to nearly all communicable and most non-communicable diseases, there is little eviden...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/sj.mp.4001777

    authors: Insel TR,Scolnick EM

    更新日期:2006-01-01 00:00:00

  • CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.

    abstract::Latency-reversing agents (LRAs), including histone deacetylase inhibitors (HDACi), are being investigated as a strategy to eliminate latency in HIV-infected patients on suppressive antiretroviral therapy. The effectiveness of LRAs in activating latent infection in HIV strains derived from the central nervous system (C...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2015.111

    authors: Gray LR,Cowley D,Welsh C,Lu HK,Brew BJ,Lewin SR,Wesselingh SL,Gorry PR,Churchill MJ

    更新日期:2016-04-01 00:00:00

  • Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders.

    abstract::Genomewide association studies have found significant genetic correlations among many neuropsychiatric disorders. In contrast, we know much less about the degree to which structural brain alterations are similar among disorders and, if so, the degree to which such similarities have a genetic etiology. From the Enhanci...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-020-01002-z

    authors: Radonjić NV,Hess JL,Rovira P,Andreassen O,Buitelaar JK,Ching CRK,Franke B,Hoogman M,Jahanshad N,McDonald C,Schmaal L,Sisodiya SM,Stein DJ,van den Heuvel OA,van Erp TGM,van Rooij D,Veltman DJ,Thompson P,Faraone SV

    更新日期:2021-01-17 00:00:00

  • Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression.

    abstract::Anxiety and depression are devastating mental illnesses that are a significant public health concern. Selective serotonin-reuptake inhibitors are the first-line treatment strategy for these disorders, which despite being a significant advantage over older treatments, are hampered by a limited efficacy in a significant...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/mp.2011.162

    authors: O'Connor RM,Dinan TG,Cryan JF

    更新日期:2012-04-01 00:00:00

  • Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5.

    abstract::Attention-deficit hyperactivity disorder (ADHD) is one of the most common childhood behavioral disorders. Genetic factors contribute to the underlying liability to develop ADHD. Reports implicate variants of genes important for the synthesis, uptake, transport and receptor binding of dopamine in the etiology of ADHD, ...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4001466

    authors: Kustanovich V,Ishii J,Crawford L,Yang M,McGough JJ,McCracken JT,Smalley SL,Nelson SF

    更新日期:2004-07-01 00:00:00

  • Vulnerability genes or plasticity genes?

    abstract::The classic diathesis-stress framework, which views some individuals as particularly vulnerable to adversity, informs virtually all psychiatric research on behavior-gene-environment (G x E) interaction. An alternative framework of 'differential susceptibility' is proposed, one which regards those most susceptible to a...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/mp.2009.44

    authors: Belsky J,Jonassaint C,Pluess M,Stanton M,Brummett B,Williams R

    更新日期:2009-08-01 00:00:00

  • What makes a drug a primary mood stabilizer?

    abstract::The term 'mood stabilizer' has been applied to a number of medications for the treatment of patients with bipolar disorder. The operational definition of the properties of a mood-stabilizing medication has varied according to the properties of specific medications and the clinical characteristics of the illness. Rando...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/sj.mp.4001013

    authors: Keck PE Jr,McElroy SL,Richtand N,Tohen M

    更新日期:2002-01-01 00:00:00

  • Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism.

    abstract::Abnormalities in the gamma-aminobutyric acid (GABA) neurotransmitter system have been noted in subjects with mood and anxiety disorders. Glutamic acid decarboxylase (GAD) enzymes synthesize GABA from glutamate, and, thus, are reasonable candidate susceptibility genes for these conditions. In this study, we examined th...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4001845

    authors: Hettema JM,An SS,Neale MC,Bukszar J,van den Oord EJ,Kendler KS,Chen X

    更新日期:2006-08-01 00:00:00

  • Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor.

    abstract::Anxiety disorders constitute a major disease and social burden worldwide; however, many questions concerning the underlying molecular mechanisms still remain open. Besides the involvement of the major excitatory (glutamate) and inhibitory (gamma aminobutyric acid (GABA)) neurotransmitter circuits in anxiety disorders,...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2016.87

    authors: Hartmann J,Dedic N,Pöhlmann ML,Häusl A,Karst H,Engelhardt C,Westerholz S,Wagner KV,Labermaier C,Hoeijmakers L,Kertokarijo M,Chen A,Joëls M,Deussing JM,Schmidt MV

    更新日期:2017-03-01 00:00:00

  • GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons.

    abstract::Translin-associated protein X (TRAX) is a scaffold protein with various functions and has been associated with mental illnesses, including schizophrenia. We have previously demonstrated that TRAX interacts with a Gsα protein-coupled receptor, the A2A adenosine receptor (A2AR), and mediates the function of this recepto...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-017-0007-z

    authors: Chien T,Weng YT,Chang SY,Lai HL,Chiu FL,Kuo HC,Chuang DM,Chern Y

    更新日期:2018-12-01 00:00:00

  • Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.

    abstract::Major depressive disorder (MDD) is associated with reduced concentrations of γ-aminobutyric acid (GABA) that are normalized by antidepressant therapies. Moreover, depressive-like phenotypes of GABAA receptor mutant mice can be reversed by treatment with conventional antidepressants drugs, as well as by subanesthetic d...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2016.188

    authors: Fuchs T,Jefferson SJ,Hooper A,Yee PH,Maguire J,Luscher B

    更新日期:2017-06-01 00:00:00

  • Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity.

    abstract::Identifying biomarkers in schizophrenia during the first episode without the confounding effects of treatment has been challenging. Leveraging these biomarkers to establish diagnosis and make individualized predictions of future treatment responses to antipsychotics would be of great value, but there has been limited ...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-018-0106-5

    authors: Cao B,Cho RY,Chen D,Xiu M,Wang L,Soares JC,Zhang XY

    更新日期:2020-04-01 00:00:00

  • Novel modalities for appraising individual and coordinate pulsatile hormone secretion: the paradigm of luteinizing hormone and testosterone release in the aging male.

    abstract::To quantify aging- and disease-associated alterations in the integrative and interactive components of a pulsatile neuroendocrine axis, novel biomathematical strategies are required. Here, I illustrate as an investigative paradigm otherwise subtle aging-dependent disturbances of the gonadotropin-releasing-hormone (GnR...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/sj.mp.4000232

    authors: Veldhuis JD

    更新日期:1997-01-01 00:00:00

  • Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus.

    abstract::Two recent association studies have implicated the neuregulin-1 gene (NRG1) at chromosome 8p21-22 as a susceptibility gene for schizophrenia. Stefansson et al identified three 'at-risk' haplotypes (HapA, B and C) which spanned the NRG1 locus and shared a common core haplotype. Subsequently, they demonstrated evidence ...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4001412

    authors: Corvin AP,Morris DW,McGhee K,Schwaiger S,Scully P,Quinn J,Meagher D,Clair DS,Waddington JL,Gill M

    更新日期:2004-02-01 00:00:00

  • An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents.

    abstract::Identifying biological mechanisms through which the experience of adversity emerges as individual risk for mental illness is an important step toward developing strategies for personalized treatment and, ultimately, prevention. Preclinical studies have identified epigenetic modification of gene expression as one such ...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2016.82

    authors: Swartz JR,Hariri AR,Williamson DE

    更新日期:2017-02-01 00:00:00

  • Liposome-based targeting of dopamine to the brain: a novel approach for the treatment of Parkinson's disease.

    abstract::Delivery of drugs into the brain is poor due to the blood brain barrier (BBB). This study describes the development of a novel liposome-based brain-targeting drug delivery system. The liposomes incorporate a diacylglycerol moiety coupled through a linker to a peptide of 5 amino acids selected from amyloid precursor pr...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-020-0742-4

    authors: Kahana M,Weizman A,Gabay M,Loboda Y,Segal-Gavish H,Gavish A,Barhum Y,Offen D,Finberg J,Allon N,Gavish M

    更新日期:2020-05-05 00:00:00

  • Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.

    abstract::Panic disorder (PD) has a lifetime prevalence of 2-4% and heritability estimates of 40%. The contributory genetic variants remain largely unknown, with few and inconsistent loci having been reported. The present report describes the largest genome-wide association study (GWAS) of PD to date comprising genome-wide geno...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-019-0590-2

    authors: Forstner AJ,Awasthi S,Wolf C,Maron E,Erhardt A,Czamara D,Eriksson E,Lavebratt C,Allgulander C,Friedrich N,Becker J,Hecker J,Rambau S,Conrad R,Geiser F,McMahon FJ,Moebus S,Hess T,Buerfent BC,Hoffmann P,Herms S,He

    更新日期:2019-11-11 00:00:00

  • RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia.

    abstract::5-HT(2C) receptor (5HT(2C)R, serotonin-2C) RNA undergoes editing to produce several receptor variants, some with pharmacological differences. This investigation comprised two parts: the characterisation of 5-HT(2C)R RNA editing in a larger human control sample than previously examined, and a comparative study in subje...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4000920

    authors: Sodhi MS,Burnet PW,Makoff AJ,Kerwin RW,Harrison PJ

    更新日期:2001-07-01 00:00:00

  • Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure.

    abstract::Exposure to traumatic events is common. While many individuals recover following trauma exposure, a substantial subset develop adverse posttraumatic neuropsychiatric sequelae (APNS) such as posttraumatic stress, major depression, and regional or widespread chronic musculoskeletal pain. APNS cause substantial burden to...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/s41380-019-0636-5

    authors: Linnstaedt SD,Zannas AS,McLean SA,Koenen KC,Ressler KJ

    更新日期:2020-09-01 00:00:00

  • Regulator of calcineurin 1 is a novel RNA-binding protein to regulate neuronal apoptosis.

    abstract::Posttranscriptional regulation of gene expression plays an important role in the maturation, transport, stability and translation of coding and noncoding RNAs. RNA-binding protein (RBP) is a key factor of the regulation. Regulator of calcineurin 1 (RCAN1) is a multifunctional protein involved in neurodegeneration, mit...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-019-0487-0

    authors: Yun Y,Zhang Y,Zhang C,Huang L,Tan S,Wang P,Vilariño-Gúell C,Song W,Sun X

    更新日期:2019-08-27 00:00:00

  • CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders.

    abstract::Contactin genes CNTN5 and CNTN6 code for neuronal cell adhesion molecules that promote neurite outgrowth in sensory-motor neuronal pathways. Mutations of CNTN5 and CNTN6 have previously been reported in individuals with autism spectrum disorders (ASDs), but very little is known on their prevalence and clinical impact....

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2016.61

    authors: Mercati O,Huguet G,Danckaert A,André-Leroux G,Maruani A,Bellinzoni M,Rolland T,Gouder L,Mathieu A,Buratti J,Amsellem F,Benabou M,Van-Gils J,Beggiato A,Konyukh M,Bourgeois JP,Gazzellone MJ,Yuen RK,Walker S,Delépine M

    更新日期:2017-04-01 00:00:00

  • Gene-environment correlations: a review of the evidence and implications for prevention of mental illness.

    abstract::Family studies have demonstrated genetic influences on environmental exposure: the phenomenon of gene-environment correlation (rGE). A few molecular genetic studies have confirmed the results, but the identification of rGE in studies that measure genes and environments faces several challenges. Using examples from stu...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,评审

    doi:10.1038/sj.mp.4001950

    authors: Jaffee SR,Price TS

    更新日期:2007-05-01 00:00:00

  • Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia.

    abstract::We previously reported that expression level of LIM (ENH, PDLIM5) was significantly and commonly increased in the brains of patients with bipolar disorder, schizophrenia, and major depression. Expression of LIM was decreased in the lymphoblastoid cells derived from patients with bipolar disorders and schizophrenia. LI...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/sj.mp.4001719

    authors: Kato T,Iwayama Y,Kakiuchi C,Iwamoto K,Yamada K,Minabe Y,Nakamura K,Mori N,Fujii K,Nanko S,Yoshikawa T

    更新日期:2005-11-01 00:00:00

  • The symptom network structure of depressive symptoms in late-life: Results from a European population study.

    abstract::The network theory conceptualizes mental disorders as complex networks of symptoms influencing each other by creating feedback loops, leading to a self-sustained syndromic constellation. Symptoms central to the network have the greatest impact in sustaining the rest of symptoms. This analysis focused on the network st...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/s41380-018-0232-0

    authors: Belvederi Murri M,Amore M,Respino M,Alexopoulos GS

    更新日期:2020-07-01 00:00:00

  • High loading of polygenic risk in cases with chronic schizophrenia.

    abstract::Genomic risk profile scores (GRPSs) have been shown to predict case-control status of schizophrenia (SCZ), albeit with varying sensitivity and specificity. The extent to which this variability in prediction accuracy is related to differences in sampling strategies is unknown. Danish population-based registers and Neon...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2015.130

    authors: Meier SM,Agerbo E,Maier R,Pedersen CB,Lang M,Grove J,Hollegaard MV,Demontis D,Trabjerg BB,Hjorthøj C,Ripke S,Degenhardt F,Nöthen MM,Rujescu D,Maier W,MooDS SCZ Consortium.,Werge T,Mors O,Hougaard DM,Børglum AD,Wra

    更新日期:2016-07-01 00:00:00

  • Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.

    abstract::Studying genetic determinants of intermediate phenotypes is a powerful tool to increase our understanding of genotype-phenotype correlations. Metabolic traits pertinent to the central nervous system (CNS) constitute a potentially informative target for genetic studies of intermediate phenotypes as their genetic underp...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2012.183

    authors: Luykx JJ,Bakker SC,Lentjes E,Neeleman M,Strengman E,Mentink L,DeYoung J,de Jong S,Sul JH,Eskin E,van Eijk K,van Setten J,Buizer-Voskamp JE,Cantor RM,Lu A,van Amerongen M,van Dongen EP,Keijzers P,Kappen T,Borgdorff P

    更新日期:2014-02-01 00:00:00

  • Genome-wide association study of Alzheimer's disease with psychotic symptoms.

    abstract::Psychotic symptoms occur in ~40% of subjects with Alzheimer's disease (AD) and are associated with more rapid cognitive decline and increased functional deficits. They show heritability up to 61% and have been proposed as a marker for a disease subtype suitable for gene mapping efforts. We undertook a combined analysi...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,meta分析,多中心研究

    doi:10.1038/mp.2011.125

    authors: Hollingworth P,Sweet R,Sims R,Harold D,Russo G,Abraham R,Stretton A,Jones N,Gerrish A,Chapman J,Ivanov D,Moskvina V,Lovestone S,Priotsi P,Lupton M,Brayne C,Gill M,Lawlor B,Lynch A,Craig D,McGuinness B,Johnston J

    更新日期:2012-12-01 00:00:00

  • Biological annotation of genetic loci associated with intelligence in a meta-analysis of 87,740 individuals.

    abstract::Variance in IQ is associated with a wide range of health outcomes, and 1% of the population are affected by intellectual disability. Despite a century of research, the fundamental neural underpinnings of intelligence remain unclear. We integrate results from genome-wide association studies (GWAS) of intelligence with ...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章,meta分析

    doi:10.1038/s41380-018-0040-6

    authors: Coleman JRI,Bryois J,Gaspar HA,Jansen PR,Savage JE,Skene N,Plomin R,Muñoz-Manchado AB,Linnarsson S,Crawford G,Hjerling-Leffler J,Sullivan PF,Posthuma D,Breen G

    更新日期:2019-02-01 00:00:00

  • Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals.

    abstract::Although therapeutic interventions in attention-deficit/hyperactivity disorder (ADHD) still focus on the dopaminergic system, recent studies indicate a serotonergic dysfunction in this disease as well. In that respect, several variants of the tryptophan hydroxylase gene (TPH2), which codes for the rate-limiting enzyme...

    journal_title:Molecular psychiatry

    pub_type: 杂志文章

    doi:10.1038/mp.2008.39

    authors: Baehne CG,Ehlis AC,Plichta MM,Conzelmann A,Pauli P,Jacob C,Gutknecht L,Lesch KP,Fallgatter AJ

    更新日期:2009-11-01 00:00:00